EUVIMEDEUVIMED entdecken
Crossref

Integrated N- and O-Glycoproteomics Reveals Site-Specific Glycosylation Dysregulation in Alzheimer’s Disease

Zhuo Zhang, Yongshuang Zhang, Xuyang Yue, Jiaying Li, Li Liu, Yaoyun Zhang, Chunxiao Yan, Lijun Zhang, Xuwei Chen iD, Yongliang Yu iD, Mingliang Ye iD, Hongqiang Qin iD

Journal of Proteome Research · 06.11.2026 · 25 (11) · 6446-6455

DOI: 10.1021/acs.jproteome.6c00644 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteome Research, online erschienen am 13.10.2026. Verfasst von Zhuo Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Northeastern University , Shenyang110819, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Proteomics, Glycopeptides, Glycoproteins. Die Arbeit nennt 28 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Dalian University of Technology, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) remains a global health challenge, in part due to the lack of reliable blood-based biomarkers for early detection and disease monitoring. Protein glycosylation critically regulates the structure and function of circulating macromolecules, yet integrated site-specific evaluation of both N- and O-glycosylation across the AD continuum remains poorly defined. Here, we performed integrated intact N- and O-glycoproteomic profiling of human serum from normal controls, patients with mild cognitive impairment (MCI), and patients with AD and identified 2,433 intact N-glycopeptides and 3,864 intact O-glycopeptides. Quantitative analysis revealed that N-glycosylation changes emerged earlier, highlighted by a marked reduction in site-specific Fc-region glycans on immunoglobulin heavy constant gamma 1 (IGHG1, Asn180) at the MCI stage, suggesting early perturbation of immune regulation. In contrast, O-glycosylation changes were broader and more progressive, exemplified by increased C-terminal O-glycoforms of apolipoprotein E (APOE) from controls to patients with MCI and AD, consistent with dysregulated lipid transport and receptor-associated functions. Together, these findings establish an integrated serum glycoproteomic atlas across the AD continuum and nominate IGHG1 and APOE glycoforms as candidate group-associated glycopeptide features. This study highlights intact glycopeptide profiling as a powerful strategy for site-specific biomarker discovery and hypothesis-generating mechanistic insight in AD progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseProteomicsGlycopeptidesGlycoproteinsHumansGlycosylationApolipoproteins ECognitive DysfunctionAgedBiomarkersFemaleMalePolysaccharides

Stichwörter der Autor:innen

alzheimer’s diseaseapolipoprotein Eglycoproteomicsglycosylation remodelingimmunoglobulin Gintact glycopeptides

Substanzen

GlycopeptidesApolipoproteins EBiomarkersGlycoproteinsPolysaccharides

Autor:innen und Institutionen

  • Northeastern University , Shenyang110819, China.
  • State Key Laboratory of Fine Chemicals, Department of Pharmaceutical Engineering, School of Chemical Engineering, Dalian University of Technology, Dalian, Liaoning116024, China.
  • State Key Laboratory of Medical Proteomics, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian116023, China.
  • University of Chinese Academy of Sciences, Beijing101408, China.
  • Department of Ophthalmology, The Third People's Hospital Affiliated to Dalian University of Technology, Dalian, Liaoning116024, China.

ORCID-Profile: Xuwei Chen, Yongliang Yu, Mingliang Ye, Hongqiang Qin

Förderung

  • National Natural Science Foundation of China
  • Dalian University of Technology
  • National Key Research and Development Program of China
  • Fundamental Research Funds for the Central Universities
  • Liaoning Revitalization Talents Program
  • Science Fund for Distinguished Young Scholars of Dalian Province

Zitieren

APA

Zhang, Z., Zhang, Y., Yue, X., Li, J., Liu, L., Zhang, Y., Yan, C., Zhang, L., Chen, X., Yu, Y., Ye, M., & Qin, H. (2026). Integrated N- and O-Glycoproteomics Reveals Site-Specific Glycosylation Dysregulation in Alzheimer’s Disease. Journal of Proteome Research, 25(11), 6446-6455. https://doi.org/10.1021/acs.jproteome.6c00644

Vancouver

Zhang Z, Zhang Y, Yue X, Li J, Liu L, Zhang Y, et al. Integrated N- and O-Glycoproteomics Reveals Site-Specific Glycosylation Dysregulation in Alzheimer’s Disease. Journal of Proteome Research. 2026;25(11):6446-6455. doi:10.1021/acs.jproteome.6c00644

BibTeX
@article{Zhang2026,
  author = {Zhang, Zhuo and Zhang, Yongshuang and Yue, Xuyang and Li, Jiaying and Liu, Li and Zhang, Yaoyun and Yan, Chunxiao and Zhang, Lijun and Chen, Xuwei and Yu, Yongliang and Ye, Mingliang and Qin, Hongqiang},
  title = {Integrated N- and O-Glycoproteomics Reveals Site-Specific Glycosylation Dysregulation in Alzheimer’s Disease},
  journal = {Journal of Proteome Research},
  year = {2026},
  volume = {25},
  number = {11},
  pages = {6446--6455},
  doi = {10.1021/acs.jproteome.6c00644}
}
Kostenlos starten →